openPR Logo
Press release

PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

03-27-2017 07:26 PM CET | Health & Medicine

Press release from: Pharmaceutical By CMI

PD-1 and PDL-1 Inhibitors Market - Global Industry Insights,

Targeted cancer therapy is the primary objective of extensive research related to cancer drugs. Our immune cells are programmed to attack the foreign cell on activation. PD-1 and PDL-1 are among those activation points present on the immune cells. Sometimes cancer cells also use this PD-1 and PDL-1 trigger points to avoid being attacked by the immune cells. Therefore, cancer drugs targeting these cells hold tremendous potential in the cancer treatment market. Approved PD-1 and PDL-1 inhibitor drugs have become blockbuster products. The global PD-1 and PDL-1 inhibitors market is segmented based on the drug type and application as follows:

Drug Type
PD-1 inhibitors
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
PDL-1 inhibitors
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Applications
Non-small cell lung cancer
Kidney cancer
Melanoma of the skin
Bladder cancer
Merkel cell skin cancer
Others

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/173

PD-1 inhibitors are effective in treating non-small-cell lung carcinoma (NSCLC), kidney cancer, melanoma of the skin, head and neck cancers, bladder cancer, and Hodgkin lymphoma. Opdivo is leading the race with US$ 3.8 Bn in sales in 2016, compared to US$ 1.4 Bn of Keytruda in 2016. Both these drugs have garnered significant development in past two years with respect to extended therapeutic application and approvals in European countries and Japan.

PDL-1 inhibitors are proven to be effective in NSCLC, bladder cancer, and Merkel cell skin cancer. Avelumab received FDA approval in March 2017 for metastatic Merkel cell carcinoma (MCC), a rare skin cancer with no approved therapies. The drug therefore, received approval under the accelerated approval process, requiring the developers, Pfizer, Inc. and Merck KGaA to conduct larger clinical trials to establish complete safety and efficacy of the drug. The drug is also being tested for bladder cancer, NSCLC, gastric cancer, ovarian cancer, and renal cancer, under the JAVELIN clinical trial program. Extended therapeutic applications widens the potential opportunity for the drugs in the global PD-1 inhibitors and PDL-1 inhibitors market.

Active research activities to spur the global PD-1 and PDL-1 inhibitors market growth

PD-1 and PDL-1 biomarkers are also called immune checkpoints. Trails from Merck & Co. and Bristol-Myers Squibb have shown PD-1 and PDL-1 inhibitors to be effective in patients expressing higher level of PD-1 and PDL-1 biomarkers, restricting the potential market to only these patients. Therefore, all of the big pharma companies in the global market of PD-1 and PDL-1 inhibitors are combining the PD-1 and PDL-1 inhibitors with other targeted cancer drugs to cater to a larger set of population. The global PD-1 and PDL-1 inhibitors market is poised to grow significantly with more product developments in the segment. There are 65 clinical studies in phase 2 and phase 3 phase globally. Commercialization of a novel drug in this segment would be a great booster for the growth for the PD-1 and PDL-1 inhibitors market.

Have a doubt? Speak to our analyst Now! https://www.coherentmarketinsights.com/insight/talk-to-analyst/173

Regional PD-1 and PDL-1 inhibitors market outlook

A major share of the revenue of the global PD-1 and PDL-1 inhibitors market is currently concentrated in North America, Europe, and Japan as these are the three major revenue generating nations with high insurance coverage, high healthcare investment, and are highly developed pharmaceutical markets. The market players would be eyeing other regions for tapping the cancer treatment market opportunities in those regions. Uncertain regulations challenging the sales of patented pharmaceutical products has been a major deterring factor for global pharmaceutical companies to enter into emerging economies. However, novel rugs for cancer type with no treatment available currently would find positive outlook in these regions, though the high pricing would inhibit their sales in emerging economies.

Key players operating in the global PD-1 and PDL-1 inhibitors market include Pfizer, Inc., Bristol-Myers Squibb, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche AG, Merck & Co. Inc., Regeneron Pharmaceuticals, Inc., Novartis AG, and Ono Pharmaceutical Co., Ltd.

You can also get exclusive discount on this CMI report by clicking on this link: https://www.coherentmarketinsights.com/insight/request-discount/173

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: http://healthcaremarketconsulting.blogspot.in/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 here

News-ID: 483192 • Views:

More Releases from Pharmaceutical By CMI

Southern Blotting Market: Global Industry Insights Analysis and Opportunity Assessment 2016-2024
Southern Blotting Market: Global Industry Insights Analysis and Opportunity Asse …
North America to dominate the southern blotting market owing to increased government funding and availability of technologies in the region The southern blotting market report covers market analysis across regions – North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Global southern blotting market is witnessing a positive trend with North America and Europe as the main engine of growth. North America and Europe are expected to capture a major
Ulcerative Colitis Market
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained
Pet Health Products Market
Pet Health Products Market
A pet or companion animal is an animal kept primarily for one's company, protection, or entertainment. Popular pets are regularly noted for their attractive appearances and their loyal or playful personalities. While dogs and cats are the most preferred pet animals, people also keep house rabbits, fancy rats, guinea pigs, parrots, chickens, and aquatic pets. The trend of pet adoption and keeping is gaining rapid traction across the globe. The
Prefilled Syringes Market
Prefilled Syringes Market
Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one

All 5 Releases


More Releases for Merck

Recombinant Human Interferon Market to Witness Huge Growth by Key Players: Roche …
The Recombinant Human Interferon report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Recombinant Human Interferon research report recognizes and
Nanobodies Market to See Booming Growth 2021-2028 | Novo Nordisk A/S, Merck & Co …
𝐍𝐚𝐧𝐨𝐛𝐨𝐝𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 top level players are analyzed in report based on current and future development status, and Nanobodies market estimations from 2021 to 2028 in terms of revenue and volume. This report provides strategic recommendations consulted by the industrial experts including market share worldwide, future outlook, cost profit structure, supply, raw materials, labour cost, manufacturing expenses, latest market trends, demands, ROI. The Nanobodies market report analyse the manufacturing cost of the
How Epigenomics Market Will Dominate In Coming Years? Key Players: Thermo Fisher …
Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996. Sample PDF Brochure https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epigenomics-market-100193 The increasing prevalence of chronic diseases such as cancer is helping the global epigenomics market to emerge with remarkable market figures, finds
Global Immune Checkpoint Inhibitors Market 2026 : Bristol-Myers Squibb, AstraZen …
Researchmoz added latest report "Global Market Study on Immune Checkpoint Inhibitors: Programmed Death Protein 1 (PD-1) Drug Class to Dominate in Terms of Value Through 2026". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Persistence Market Research (PMR) offers an 8-year forecast on the global immune checkpoint inhibitors market. The primary objective of the report is to offer
Pharmaceuticals Excipients Market 2018 Global Analysis By Key Players – Ashlan …
Summary WiseGuyReports.com adds “Pharmaceuticals Excipients Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database. This report provides in depth study of “Pharmaceuticals Excipients Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmaceuticals Excipients Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ https://goo.gl/793aS1 The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.